← Back to patent-cliff list
Paclitaxel Polymeric Micelles(Tumor Research Institute Chinese Academy Of Medical Sciences)
Tier C — Watch / tradePaclitaxel Polymeric Micelles(Tumor Research Institute Chinese Academy Of Medical Sciences)
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Tubulin
Indications (approved)：三阴性乳腺癌
Regional status
US
-
EU
-
China
Phase III
2025-07-21
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Paclitaxel Polymeric Micelles(Tumor Research Institute Chinese Academy Of Medical Sciences)?
Approved indications include: 三阴性乳腺癌.
When does the Paclitaxel Polymeric Micelles(Tumor Research Institute Chinese Academy Of Medical Sciences) patent expire?
No public expiry year is available for Paclitaxel Polymeric Micelles(Tumor Research Institute Chinese Academy Of Medical Sciences) yet; this page updates once verified.
How do I get a quote for Paclitaxel Polymeric Micelles(Tumor Research Institute Chinese Academy Of Medical Sciences) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-30